Literature DB >> 1373782

Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma.

C W Graham1, J H Lynch, D Djakiew.   

Abstract

Recent observations from our laboratory have identified a nerve growth factor (NGF)-like protein in conditioned media of stromal cells and neoplastic epithelial cells of the human prostate which mediates paracrine interactive growth of both cell types in vitro. In order to investigate the location of this NGF-like protein in the human prostate in vivo, and whether a nerve growth factor receptor (NGF-R) could be identified, we have carried out immunocytochemical studies on frozen tissue sections of human benign prostatic hyperplasia (BPH), prostatic adenocarcinoma and normal prostatic tissue. The NGF-like protein localized predominantly to the stromal component of BPH, adenocarcinoma and normal (non-cancerous) prostatic tissue. Conversely, the NGF-R localized predominantly to the epithelial cells of these tissues. Renal tissue provided negative controls for both the NGF-like protein and the NGF-R. The testis provided positive controls for both the NGF-like protein and the NGF-R. These results provide corroborative evidence for a NGF-like protein produced by stromal cells which interacts with a NGF-R on the adjacent epithelial cells thereby mediating paracrine interactive growth regulation of the human prostate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373782     DOI: 10.1016/s0022-5347(17)37590-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Prostate gland: structure, functions and regulation.

Authors:  V L Kumar; P K Majumder
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells.

Authors:  A A Geldof; M A De Kleijn; B R Rao; D W Newling
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.

Authors:  E T Walch; D Marchetti
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 4.  Growth factors as mediators of androgen action during the development of the male urogenital tract.

Authors:  G R Cunha; B Foster; A Thomson; Y Sugimura; N Tanji; M Tsuji; N Terada; P W Finch; A A Donjacour
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  OMIP-040: Optimized gating of human prostate cellular subpopulations.

Authors:  Gervaise H Henry; Nicolas Loof; Douglas W Strand
Journal:  Cytometry A       Date:  2017-08-18       Impact factor: 4.355

Review 6.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 7.  Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer.

Authors:  J L Ware
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

8.  Effects of castration on the expression of the NGF and TrkA in the vas deferens and accessory male genital glands of the rat.

Authors:  C Squillacioti; A De Luca; S Paino; E Langella; N Mirabella
Journal:  Eur J Histochem       Date:  2009-12-29       Impact factor: 3.188

9.  The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.

Authors:  A B Paul; E S Grant; F K Habib
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Nerve growth factor signaling following unilateral pelvic ganglionectomy in the rat ventral prostate is age dependent.

Authors:  Carol A Podlasek; Rudrani Ghosh; Omer Onur Cakir; Christopher Bond; Kevin E McKenna; Kevin T McVary
Journal:  Asian J Androl       Date:  2013-07-22       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.